/Merck%20%26%20Co%20Inc%20HQ%20-by%20Sundry%20Photography%20via%20iStock.jpg)
Valued at a market cap of $207.8 billion, Merck & Co., Inc. (MRK) is a leading healthcare company based in Rahway, New Jersey. It develops and markets human health pharmaceuticals across key therapeutic areas like oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes. Additionally, it offers veterinary medicines, vaccines, and health management solutions and services for both livestock and companion animals.
Companies worth $200 billion or more are typically classified as “mega-cap stocks,” and MRK fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the drug manufacturers - general industry. The company’s strength lies in its strong research and development (R&D) capabilities, which fuel its leadership in innovative medicines and vaccines. The combination of cutting-edge innovation, a robust product pipeline, and global market presence positions Merck as a key player in advancing healthcare worldwide.